Featured Posts
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Search Posts
News Release
Senate Big Beautiful Bill Contains Needed Medicaid Reforms
The Senate today voted 51 to 50 to pass the Reconciliation package known as the “One Big Beautiful Bill,” following House passage in…
Blog
FDA can’t stomach fluoride and doesn’t want you to, either
On May 13, the Food and Drug Administration (FDA) announced that it would begin a process intended to exclude ingestible prescription fluoride products…
Blog
The MAHA Report is a missed opportunity
Less than six months into the new administration, the Department of Health and Human Services (HHS) has produced its Make Our Children Healthy…
Blog
CBO likely overestimates effects of Medicaid reforms
Yesterday, the Congressional Budget Office (CBO) released its estimates of the costs, both financial and in coverage, of the One Big Beautiful Bill…
News Release
MAHA Commission recommendations on improving government-directed research merit consideration
President Trump’s Make America Healthy Again Commission released the “Making Our Children Health Again” report, which seeks to evaluate health trends among America’s…
The Washington Examiner
Capping drug prices will cripple innovation and harm public health
The Washington Examiner cited CEI’s expert on life-saving drugs and technology The Competitive Enterprise Institute was similarly scathing. “As with many industries, the…